Q4 2019 Holdings
Filed 2020-02-14 | 12 holdings | $19.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| argenx SE(ARGX) | Common | 04016X101 | $11.5M | 71,700 | 59.3% |
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $7.1M | 855,437 | 36.6% |
| Autolus Therapeutics Limited(AUTL) | Common | 05280R100 | $525.0K | 39,740 | 2.7% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $57.7K | 3,898,422 | 0.3% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $57.4K | 2,331,534 | 0.3% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $48.1K | 3,370,982 | 0.2% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $37.6K | 1,423,794 | 0.2% |
| ArQule, Inc.(ARQLUSD) | Common | 04269E107 | $21.8K | 1,094,210 | 0.1% |
| MEI Pharma, Inc. | Common | 552798202 | $15.5K | 6,250,000 | 0.1% |
| Deciphera Pharmaceuticals, Inc.(DCPHEUR) | Common | 24344T101 | $13.4K | 215,570 | 0.1% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $10.5K | 337,291 | 0.1% |
| Sunesis Pharmaceuticals, Inc. | Common | 867328700 | $949 | 2,809,912 | 0.0% |